{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:12:45Z","timestamp":1790518365508,"version":"4.1.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute myeloid leukemia (AML) is a heterogenous malignancy characterized by distinct lineage subtypes and various genetic\/epigenetic alterations. As with other neoplasms, AML cells have well-known aerobic glycolysis, but metabolic variations depending on cellular lineages also exist. Lysine-specific demethylase-1 (LSD1) has been reported to be crucial for human leukemogenesis, which is currently one of the emerging therapeutic targets. However, metabolic roles of LSD1 and lineage-dependent factors remain to be elucidated in AML cells. Here, we show that LSD1 directs a hematopoietic lineage-specific metabolic program in AML subtypes. Erythroid leukemia (EL) cells particularly showed activated glycolysis and high expression of LSD1 in both AML cell lines and clinical samples. Transcriptome, chromatin immunoprecipitation\u2013sequencing, and metabolomic analyses revealed that LSD1 was essential not only for glycolysis but also for heme synthesis, the most characteristic metabolic pathway of erythroid origin. Notably, LSD1 stabilized the erythroid transcription factor GATA1, which directly enhanced the expression of glycolysis and heme synthesis genes. In contrast, LSD1 epigenetically downregulated the granulo-monocytic transcription factor C\/EBP\u03b1. Thus, the use of LSD1 knockdown or chemical inhibitor dominated C\/EBP\u03b1 instead of GATA1 in EL cells, resulting in metabolic shifts and growth arrest. Furthermore, GATA1 suppressed the gene encoding C\/EBP\u03b1 that then acted as a repressor of GATA1 target genes. Collectively, we conclude that LSD1 shapes metabolic phenotypes in EL cells by balancing these lineage-specific transcription factors and that LSD1 inhibitors pharmacologically cause lineage-dependent metabolic remodeling.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020003521","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T15:37:50Z","timestamp":1619797070000},"page":"2305-2318","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":26,"title":["LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C\/EBP\u03b1"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-5439","authenticated-orcid":false,"given":"Kensaku","family":"Kohrogi","sequence":"first","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"},{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Hino","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8370-6292","authenticated-orcid":false,"given":"Kotaro","family":"Anan","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"},{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-2647","authenticated-orcid":false,"given":"Ryuta","family":"Takase","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hino","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-2454","authenticated-orcid":false,"given":"Kazutaka","family":"Araki","sequence":"additional","affiliation":[{"name":"Biological Data Science Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Bioinformatics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-2428","authenticated-orcid":false,"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-8673","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"issue":"1","key":"2021043015323244200_B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"issue":"19","key":"2021043015323244200_B2","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/onc.2016.411","article-title":"Cancer heterogeneity is not compatible with one unique cancer cell metabolic map","volume":"36","author":"Strickaert","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"2021043015323244200_B3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.molcel.2019.08.028","article-title":"Metabolic diversity in human non-small cell lung cancer cells","volume":"76","author":"Chen","year":"2019","journal-title":"Mol Cell"},{"issue":"2","key":"2021043015323244200_B4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic signatures of cancer cells and stem cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nat Metab"},{"issue":"8","key":"2021043015323244200_B5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc1947","article-title":"Lineage dependency and lineage-survival oncogenes in human cancer [published correction appears in Nat Rev Cancer. 2006;6(9):742]","volume":"6","author":"Garraway","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2021043015323244200_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab"},{"issue":"5","key":"2021043015323244200_B7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"2021043015323244200_B8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2021043015323244200_B9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.molmed.2007.09.003","article-title":"Right on target: eradicating leukemic stem cells","volume":"13","author":"Krause","year":"2007","journal-title":"Trends Mol Med"},{"issue":"6","key":"2021043015323244200_B10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","article-title":"Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"issue":"10","key":"2021043015323244200_B11","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/leu.2017.45","article-title":"ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition","volume":"31","author":"Ju","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"2021043015323244200_B12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"2021043015323244200_B13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.stem.2014.06.002","article-title":"Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification [published correction appears in Cell Stem Cell. 2014;15(5):666-8]","volume":"15","author":"Oburoglu","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2021043015323244200_B14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.canep.2015.06.009","article-title":"Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data","volume":"39","author":"Hossain","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"7158","key":"2021043015323244200_B15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature06092","article-title":"p53 Is regulated by the lysine demethylase LSD1","volume":"449","author":"Huang","year":"2007","journal-title":"Nature"},{"issue":"50","key":"2021043015323244200_B16","doi-asserted-by":"crossref","first-page":"21499","DOI":"10.1073\/pnas.1016147107","article-title":"Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2021043015323244200_B17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/cas.13004","article-title":"Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells","volume":"107","author":"Hino","year":"2016","journal-title":"Cancer Sci"},{"issue":"7","key":"2021043015323244200_B18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tem.2019.04.010","article-title":"Distinct roles of the NAD+-Sirt1 and FAD-LSD1 pathways in metabolic response and tissue development","volume":"30","author":"Nakao","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"2021043015323244200_B19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/0008-5472.CAN-14-1560","article-title":"Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells","volume":"75","author":"Sakamoto","year":"2015","journal-title":"Cancer Res"},{"issue":"2","key":"2021043015323244200_B20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.29714","article-title":"Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer","volume":"138","author":"Kosumi","year":"2016","journal-title":"Int J Cancer"},{"issue":"4","key":"2021043015323244200_B21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molcel.2007.06.039","article-title":"Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1","volume":"27","author":"Saleque","year":"2007","journal-title":"Mol Cell"},{"key":"2021043015323244200_B22","doi-asserted-by":"crossref","first-page":"e00633","DOI":"10.7554\/eLife.00633","article-title":"Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation","volume":"2","author":"Kerenyi","year":"2013","journal-title":"eLife"},{"issue":"1","key":"2021043015323244200_B23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood-2014-04-569525","article-title":"Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms","volume":"124","author":"Niebel","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2021043015323244200_B24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm.2661","article-title":"Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat Med"},{"issue":"7","key":"2021043015323244200_B25","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-15-2333","article-title":"Pharmacological inhibition of the histone lysine demethylase KDM1A suppresses the growth of multiple acute myeloid leukemia subtypes","volume":"76","author":"McGrath","year":"2016","journal-title":"Cancer Res"},{"issue":"2","key":"2021043015323244200_B26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1535-7163.MCT-16-0471","article-title":"A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML cells","volume":"16","author":"Ishikawa","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2021043015323244200_B27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ccell.2018.02.002","article-title":"ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia","volume":"33","author":"Maes","year":"2018","journal-title":"Cancer Cell"},{"issue":"12","key":"2021043015323244200_B28","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.exphem.2013.09.003","article-title":"Elucidation of the role of LMO2 in human erythroid cells","volume":"41","author":"Inoue","year":"2013","journal-title":"Exp Hematol"},{"issue":"2","key":"2021043015323244200_B29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cell.2009.12.041","article-title":"The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1\u03b1","volume":"140","author":"Zhong","year":"2010","journal-title":"Cell"},{"issue":"7","key":"2021043015323244200_B30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/MCB.01404-14","article-title":"Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells","volume":"35","author":"Nagaoka","year":"2015","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2021043015323244200_B31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"2021043015323244200_B32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncomms1755","article-title":"FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure","volume":"3","author":"Hino","year":"2012","journal-title":"Nat Commun"},{"issue":"11","key":"2021043015323244200_B33","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1093\/nar\/gky234","article-title":"LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation","volume":"46","author":"Anan","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"2021043015323244200_B34","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"4","key":"2021043015323244200_B35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"issue":"4","key":"2021043015323244200_B36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","article-title":"Genomic subtyping and therapeutic targeting of acute erythroleukemia","volume":"51","author":"Iacobucci","year":"2019","journal-title":"Nat Genet"},{"issue":"22","key":"2021043015323244200_B37","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"7391","key":"2021043015323244200_B38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2021043015323244200_B39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"issue":"2","key":"2021043015323244200_B40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","article-title":"Erythroleukemia-historical perspectives and recent advances in diagnosis and management","volume":"32","author":"Boddu","year":"2018","journal-title":"Blood Rev"},{"issue":"6","key":"2021043015323244200_B41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"4","key":"2021043015323244200_B42","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood-2002-07-2321","article-title":"Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency","volume":"101","author":"van Wijk","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2021043015323244200_B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embr.201846255","article-title":"ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data","volume":"19","author":"Oki","year":"2018","journal-title":"EMBO Rep"},{"issue":"4","key":"2021043015323244200_B44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrc2348","article-title":"GATA1-related leukaemias","volume":"8","author":"Shimizu","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"2021043015323244200_B45","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2016-01-695759","article-title":"An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation","volume":"127","author":"Avellino","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2021043015323244200_B46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12185-014-1568-0","article-title":"A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation","volume":"100","author":"Moriguchi","year":"2014","journal-title":"Int J Hematol"},{"issue":"13","key":"2021043015323244200_B47","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1016\/j.celrep.2018.03.012","article-title":"Enhancer activation by pharmacologic displacement of LSD1 from GFI1 induces differentiation in acute myeloid leukemia","volume":"22","author":"Maiques-Diaz","year":"2018","journal-title":"Cell Rep"},{"issue":"25","key":"2021043015323244200_B48","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1073\/pnas.0900437106","article-title":"LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis","volume":"106","author":"Hu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021043015323244200_B49","doi-asserted-by":"crossref","first-page":"191048","DOI":"10.1098\/rsos.191048","article-title":"The histone H3K4 demethylase JARID1A directly interacts with haematopoietic transcription factor GATA1 in erythroid cells through its second PHD domain","volume":"7","author":"Karia","year":"2020","journal-title":"R Soc Open Sci"},{"issue":"5","key":"2021043015323244200_B50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2020.03.022","article-title":"C\/EBP\u03b1 and GATA-2 mutations induce bilineage acute erythroid leukemia through transformation of a neomorphic neutrophil-erythroid progenitor","volume":"37","author":"Di Genua","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"2021043015323244200_B51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"issue":"1","key":"2021043015323244200_B52","first-page":"1","article-title":"Methylation-dependent regulation of HIF-1\u03b1 stability restricts retinal and tumour angiogenesis","volume":"7","author":"Kim","year":"2016","journal-title":"Nat Commun"},{"issue":"24","key":"2021043015323244200_B53","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1128\/MCB.24.24.10814-10825.2004","article-title":"Leukemogenesis caused by incapacitated GATA-1 function","volume":"24","author":"Shimizu","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2021043015323244200_B54","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.2019003062","article-title":"Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers","volume":"136","author":"Fagnan","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2021043015323244200_B55","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1038\/s41467-020-16179-8","article-title":"Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia","volume":"11","author":"Leonards","year":"2020","journal-title":"Nat Commun"},{"issue":"7123","key":"2021043015323244200_B56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature05378","article-title":"Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1","volume":"445","author":"Ribeil","year":"2007","journal-title":"Nature"},{"issue":"1","key":"2021043015323244200_B57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2009-09-241778","article-title":"HSP27 controls GATA-1 protein level during erythroid cell differentiation","volume":"116","author":"de Thonel","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2021043015323244200_B58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","article-title":"Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP \u03b1","volume":"21","author":"Zhang","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"2021043015323244200_B59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/bloodadvances.2017012781","article-title":"C\/EBP\u03b1 overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia","volume":"2","author":"Loke","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"2021043015323244200_B60","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.celrep.2013.03.003","article-title":"C\/EBP\u03b1 induces highly efficient macrophage transdifferentiation of B lymphoma and leukemia cell lines and impairs their tumorigenicity [published correction appears in Cell Rep. 2017;19(6):1281]","volume":"3","author":"Rapino","year":"2013","journal-title":"Cell Rep"},{"issue":"5","key":"2021043015323244200_B61","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrc1363","article-title":"C\/EBPalpha mutations in acute myeloid leukaemias","volume":"4","author":"Nerlov","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2021043015323244200_B62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nat Genet"},{"issue":"8","key":"2021043015323244200_B63","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/cells8080805","article-title":"Metabolic plasticity of acute myeloid leukemia","volume":"8","author":"Kreitz","year":"2019","journal-title":"Cells"},{"issue":"1","key":"2021043015323244200_B64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-019-0811-9","article-title":"LSD1\/KDM1A inhibitors in clinical trials: advances and prospects","volume":"12","author":"Fang","year":"2019","journal-title":"J Hematol Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/9\/2305\/1806172\/advancesadv2020003521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/9\/2305\/1806172\/advancesadv2020003521.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T15:38:51Z","timestamp":1619797131000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/9\/2305\/475840\/LSD1-defines-erythroleukemia-metabolism-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,5,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003521","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]}}}